<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Presgera - Scientific References</title>
    <style>
      body {
        font-family: Arial, sans-serif;
        line-height: 1.6;
        background-color: #f4f4f4;
        padding: 20px;
      }

      .container {
        max-width: 800px;
        margin: 0 auto;
        background: #fff;
        padding: 20px;
        border-radius: 8px;
        box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
      }

      h1 {
        font-size: 28px;
        color: #333;
      }

      p,
      ul {
        margin: 12px 0;
        color: #555;
      }

      ul {
        padding-left: 20px;
        list-style-type: disc;
      }

      ul li {
        margin: 8px 0;
      }

      .date-effective {
        font-weight: bold;
        margin-top: 20px;
      }

      .reference {
        margin-bottom: 15px;
      }

      .reference p {
        margin: 5px 0;
        font-size: 16px;
        color: #333;
      }

      .reference a {
        color: #0066cc;
        text-decoration: none;
      }
    </style>
  </head>

  <body>
    <div class="container">
      <h1>Scientific References</h1>
      <div class="reference">
        <p>
          Cinar V, Polat Y, Baltaci AK, Mogulkoc R. Effects of magnesium
          supplementation on testosterone levels of athletes and sedentary
          subjects at rest and after exhaustion. Biol Trace Elem Res. 2011
          Apr;140(1):18-23. doi: 10.1007/s12011-010-8676-3. PMID: 20352370.
        </p>
      </div>
      <div class="reference">
        <p>
          Maggio M, De Vita F, Lauretani F, Nouvenne A, Meschi T, Ticinesi A,
          Dominguez LJ, Barbagallo M, Dall'aglio E, Ceda GP. The Interplay
          between Magnesium and Testosterone in Modulating Physical Function in
          Men. Int J Endocrinol. 2014;2014:525249. doi: 10.1155/2014/525249.
          PMID: 24723948; PMCID: PMC3958794.
        </p>
      </div>
      <div class="reference">
        <p>
          Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci. 2002
          Nov;5(Suppl):1062-7. doi: 10.1038/nn942. PMID: 12403983.
        </p>
      </div>
      <div class="reference">
        <p>
          Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the
          pharmacological treatment of neuropathic pain: 2010 revision. Eur J
          Neurol. 2010 Sep;17(9):1113-e88. doi:
          10.1111/j.1468-1331.2010.02999.x. PMID: 20402746.
        </p>
      </div>

      <div class="reference">
        <p>
          Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact
          on quality of life. Curr Pain Headache Rep. 2012 Jun;16(3):191-8. doi:
          10.1007/s11916-012-0256-0. PMID: 22453537.
        </p>
      </div>
      <div class="reference">
        <p>
          Dworkin RH, O'Connor AB, Kent J, et al. Interventional management of
          neuropathic pain: NeuPSIG recommendations. Pain. 2013
          Nov;154(11):2249-2261. doi: 10.1016/j.pain.2013.06.004. PMID:
          23748119.
        </p>
      </div>

      <div class="reference">
        <p>
          Jensen TS, Baron R. Translation of symptoms and signs into mechanisms
          in neuropathic pain. Pain. 2003 Dec;102(1-2):1-8. doi:
          10.1016/s0304-3959(03)00047-4. PMID: 12620600.
        </p>
      </div>
      <div class="reference">
        <p>
          Murnion BP. Neuropathic pain: current definition and review of drug
          treatment. Aust Prescr. 2010 Dec;33(6):190-193. doi:
          10.18773/austprescr.2010.091.
        </p>
      </div>
      <p>
        &copy; Presgera Research 2023 All Rights Reserved. 19655 E 35th Drive
        Suite 100 Aurora, CO 80011
      </p>
    </div>
  </body>
</html>
